SJS Investment Consulting’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34K Sell
1,235
-457
-27% -$15K ﹤0.01% 602
2026
Q1
$63K Buy
1,692
+312
+23% +$12.9K 0.01% 304
2025
Q4
$64.6K Buy
1,380
+217
+19% +$9.38K 0.01% 277
2025
Q3
$48.7K Buy
1,163
+1,148
+7,653% +$50.5K 0.01% 326
2025
Q2
$661 Sell
15
-20
-57% -$906 ﹤0.01% 1015
2025
Q1
$1.76K Buy
35
+11
+46% +$545 ﹤0.01% 781
2024
Q4
$1.03K Sell
24
-6
-20% -$253 ﹤0.01% 990
2024
Q3
$1.18K Sell
30
-1
-3% -$36 ﹤0.01% 1007
2024
Q2
$998 Buy
31
+2
+7% +$65 ﹤0.01% 1026
2024
Q1
$956 Hold
29
﹤0.01% 1054
2023
Q4
$1.01K Sell
29
-7
-19% -$241 ﹤0.01% 953
2023
Q3
$1.3K Buy
36
+18
+100% +$668 ﹤0.01% 812
2023
Q2
$677 Sell
18
-21
-54% -$845 ﹤0.01% 1053
2023
Q1
$1.8K Sell
39
-2
-5% -$93 ﹤0.01% 635
2022
Q4
$1.9K Buy
41
+2
+5% +$91 ﹤0.01% 655
2022
Q3
$2K Buy
+39
New +$1.79K ﹤0.01% 465
2022
Q1
$0 Buy
+5
New +$232 ﹤0.01% 936

Other funds holding G

SJS Investment Consulting's G Position: Q2 2026 in Review

SJS Investment Consulting reduced its Genpact (G) stake by 27% in Q2 2026, selling an estimated $15K and leaving 1,235 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #602.

SJS Investment Consulting first reported a position in G in Q1 2022 and has held it in 17 quarters since. The position peaked at $64.6K in Q4 2025. 234 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • SJS Investment Consulting held 1,235 shares of Genpact worth $34K as of Q2 2026.
  • SJS Investment Consulting sold 457 Genpact shares in Q2 2026, an estimated $15K.
  • Genpact made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #602 holding.
  • SJS Investment Consulting first reported a position in Genpact in Q1 2022 and has held it in 17 quarters since.
  • SJS Investment Consulting's Genpact position peaked at $64.6K in Q4 2025.
  • 234 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.